Biom Pharmaceutical Corporation operates in Research, functioning as Distributor and Exporter and Supplier and Manufacturer, based in United States, founded in 2016.
Biom Pharmaceutical Corporation is active in Research, with 3 identified product associations including VAGIBIOM, LONGIVA, and 3 ingredient links such as Cranberry Extract - Extract, Bifidobacterium Brevis - Probiotic, operating from United States.
Biom Pharmaceutical Corporation is linked to 3 ingredients: Cranberry Extract - Extract, Bifidobacterium Brevis - Probiotic, Turmeric - Nano-Formulated. INCI names include varies by source, Brevis Extract. CAS references: 84929-27-1, 123-45-6.
Biom Pharmaceutical Corporation has 3 product records: VAGIBIOM, LONGIVA, BIOM THERAPEUTICS, under brands: BIOMPHARMA, within the Research ecosystem.
Biom Pharmaceutical Corporation has 10 people records, including Gm & Svp Of Operations Consumer Care, Vice President, Clinical And Hospital Marketing, across Vp, Founder levels.
This profile combines organization, product, ingredient, and narrative signals into a higher-fidelity company record.
CAS: 84929-27-1 · INCI: varies by source
CAS: 123-45-6 · INCI: Brevis Extract
CAS: 458-37-7
Brand: BIOMPHARMA · Industry: Research
Brand: BIOMPHARMA · Industry: Research
Brand: BIOMPHARMA · Industry: Research
Biom Pharmaceutical Corporation has 10 people records, including Gm & Svp Of Operations Consumer Care, Vice President, Clinical And Hospital Marketing, across Vp, Founder levels.
Biom Pharmaceutical Corporation is related to companies such as National Electrostatics Corp., ELECTROTEK LIMITED, Jiangsu Pailezi Food Co., Ltd., identified through shared industry signals, ingredient overlap, and product ecosystem alignment.
Data-backed questions about Biom Pharmaceutical Corporation in Research, United States.
Biom Pharmaceutical Corporation is linked to 3 product records: VAGIBIOM, LONGIVA, BIOM THERAPEUTICS.
Biom Pharmaceutical Corporation is associated with 3 ingredients: Cranberry Extract - Extract, Bifidobacterium Brevis - Probiotic, Turmeric - Nano-Formulated. INCI names include: varies by source, Brevis Extract.
Biom Pharmaceutical Corporation operates in Research, with operations based in United States.
Biom Pharmaceutical Corporation was founded in 2016, making it 10 years active, headquartered in United States.
Biom Pharmaceutical Corporation is headquartered at 2203 Industrial Boulevard, Sarasota, Florida 34234, United States, United States.
Disclaimer: All information contained in this database has been researched and compiled from many legitimate sources, believed to be accurate and reliable at the time of publishing. However, in view of the natural scope for human and/or mechanical error, either at source or during production, Dietary Business Intelligence (DBI) ( www.dbi360.com ) accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the database. All information is provided without warranty, and DBI makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained and strongly encourages that upon final material or product selection data points are validated with the supplier.
© Copyright 2026 Dietary Business Intelligence LLC. All Rights Reserved.
